YOUR BUSINESS AUTHORITY
Springfield, MO
Loxo Oncology Inc. and Bayer are collaborating to develop and commercialize two cancer drugs.
The deal could bring the U.S. drug developer up to $1.55 billion.
Loxo will receive a $400 million upfront payment, followed by incentive payments for milestones.
Read more from RTT News.
Organizers hope to bolster client traffic to center city businesses.